The Current Ratio as of November 2024 (TTM) for Onconova Therapeutics, Inc. (ONTX) is 1.93

According to Onconova Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.93. This represents a change of -27.91% compared to the average of 2.67 of the last 4 quarters.

Onconova Therapeutics, Inc. (ONTX) Historical Current Ratio (quarterly & annually)

How has ONTX Current Ratio performed in the past?

The mean historical Current Ratio of Onconova Therapeutics, Inc. over the last ten years is 3.37. The current 1.93 Current Ratio has changed 5.62% with respect to the historical average. Over the past ten years (40 quarters), ONTX's Current Ratio was at its highest in in the December 2021 quarter at 9.06. The Current Ratio was at its lowest in in the December 2017 quarter at 0.49.

Onconova Therapeutics, Inc. (ONTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Onconova Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Onconova Therapeutics, Inc. (ONTX) Average Current Ratio

How has ONTX Current Ratio performed in the past?

The current Current Ratio of Onconova Therapeutics, Inc. (ONTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Onconova Therapeutics, Inc. (ONTX) Current Ratio vs. Peers

How is ONTX’s Current Ratio compared to its peers?

Onconova Therapeutics, Inc.’s Current Ratio is greater than Jaguar Health, Inc. (1.84), less than iBio, Inc. (3.37), less than GeoVax Labs, Inc. (4.17), less than Ocugen, Inc. (2.58), less than Tonix Pharmaceuticals Holding Corp. (3.33), greater than Sonnet BioTherapeutics Holdings, Inc. (1.65), less than Palisade Bio, Inc. (3.31), less than Adial Pharmaceuticals, Inc. (6.78), less than Diffusion Pharmaceuticals Inc. (10.96), less than Aeterna Zentaris Inc. (5.94), less than Pulmatrix, Inc. (19.40), greater than Catalyst Biosciences, Inc. (0), greater than Bio-Path Holdings, Inc. (0.86), less than Moleculin Biotech, Inc. (2.08), greater than Vaxart, Inc. (0.83), greater than VBI Vaccines Inc. (0.34),

Build a custom stock screener for Onconova Therapeutics, Inc. (ONTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Onconova Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Onconova Therapeutics, Inc. (ONTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Onconova Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.